The controversies regarding the role of estrogens in urogynecology

Folia Histochemica et Cytobiologica

Volumn 45, Issue SUPPL. 1, 2007, Pages 17-21

  Rechberger, Tomasz ^a,b   Skorupski, Paweł ^a  

^a MEDICAL UNIVERSITY OF LUBLIN   (Poland)

^b MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

Estrogen; Lower urinary tract; Menopause

Indexed keywords

CONJUGATED ESTROGEN; CONJUGATED ESTROGEN PLUS MEDROXYPROGESTERONE ACETATE; ESTROGEN; PLACEBO;

CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; ESTROGEN ACTIVITY; ESTROGEN THERAPY; EVIDENCE BASED MEDICINE; FEMALE; HORMONE SUBSTITUTION; HUMAN; MENOPAUSE; OVERACTIVE BLADDER; PELVIC ORGAN PROLAPSE; STRESS INCONTINENCE; TISSUE METABOLISM; URGE INCONTINENCE;

EID: 44949258979     PISSN: 02398508     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (37)

1. Van Geelen JM, Doesburg WH, Thomas CM, Martin CB Jr. Urodynamic studies in the normal menstrual cycle: the relationship between hormonal changes during the menstrual cycle and the urethral pressure profile. Am J Obstet Gynecol. 1981;141:384-92.
2. Cutner A., Carey A., Cardozo L.D. Lower urinary tract in early pregnancy. J Obstet Gynecol. 1992;12:75-78.
3. Hextall A, Bidmead J, Cardozo L, Hooper R. The impact of the menstrual cycle on urinary symptoms and the results of urodynamic investigation. BJOG. 2001;108:1193-1196.
4. Fowler CJ, Christmas TJ, Chappie CR, Parkhouse HF, Kirby RS, Jacobs HS. Abnormal electromyographic activity of the urethral sphincter, voiding dysfunction, and polycystic ovaries: a new syndrome? BMJ. 1988;297:1436-1438.
5. Jolleys JV. Reported prevalence of urinary incontinence in women in a general practice. Br Med J (Clin Res Ed). 1988;296:1300-1302.
6. Cardozo LD, Rekers H, Tapp A. Oestriol in the treatment of postmenopausal urgency: a multicenter study. Maturitas. 2003;45:47-53.
7. Samsioe G. Urogenital aging - a hidden problem. Am J Obstet Gynecol. 1998;178:S245-9.
8. Hextall A, Cardozo L. The role of estrogen supplementation in lower urinary tract dysfunction. Int Urogynecol J Pelvic Floor Dysfunct. 2001;12:258-261.
9. Dessole S, Rubattu G, Ambrosini G, et al. Efficacy of low-dose intravaginal estriol on urogenital aging in post-menopausal women. Menopause. 2004;11:49-56.
10. Falconer C, Ekman G, Malmström A, Ulmsten U. Decreased collagen synthesis in stress-incontinent women. Obstet Gynecol. 1994;84:583-586.
11. Jackson S, Shepherd A, Brookes S, Abrams P. The effect of oestrogen supplementation on post-menopausal urinary stress incontinence: a double-blind placebo-controlled trial. Br J Obstet Gynaecol. 1999;106:711-718.
12. Rechberger T, Postawski K, Jakowicki JA, Gunja-Smith Z, Woessner JF Jr. Role of fascial collagen in stress urinary incontinence. Am J Obstet Gynecol. 1998;179:1511-1514.
13. Holland EF, Studd JW, Mansell JP, Leather AT, Bailey AJ. Changes in collagen composition and cross-links in bone and skin of osteoporotic postmenopausal women treated with percutaneous estradiol implants. Obstet Gynecol. 1994;83:180-183.
14. Fantl JA, Cardozo L, McClish DK. Estrogen therapy int he management of urinary incontinence in postmenopausal women: a meta-analysis. First report of the Hormones and Urogenital Therapy Committee. Obstet Gynecol. 1994;83:12-18.
15. Jarmy-Di Bella ZI, Girao MJ, Sartori MF, et al. Power Doppler of the urethra in continent or incontinent, pre- and post-menopausal women. Int Urogynecol J Pelvic Floor Dysfunct. 2000;1:148-154.
16. Beisland HO, Fossberg E, Moer A, Sander S. Urethral sphincteric insufficiency in postmenopausal females: treatment with phenylpropanolamine and estriol separately and in combination. A urodynamic and clinical evaluation. Urol Int. 1984;39:211-216.
17. Cardozo L, Bachmann G, McClish D, Fonda D, Birgerson L. Meta-analysis of estrogen therapy in the management of urogenital atrophy in postmenopausal women: second report of the Hormones and Urogenital Therapy Committee. Obst Gynecol. 1998;92:722-727.
18. Moehrer B, Hextall A, Jackson S. Oestrogens for urinary incontinence in women. Cochrane Database of Systematic Reviews 2003, Issue 2. Art. No.: CD001405. DOI:10.1002/14651858.CD001405
19. Osamu Ishiko O, Hirai K, Ogita S. Hormone Replacement Therapy plus pelvic Floor Musle Exercise for Post-menopausal Stress Incontinence. J Reprod Med. 2001;46:213-220.
20. Grady D, Brown JS, Vittinghoff E, Applegate W, Varner E, Snyder T. Postmenopausal hormones and incontinence: the Heart and Estrogen/Progestin Replacement Study. Obstet Gynecol. 2001;97:116-120.
21. Hendrix SL, Cochrane BB, Nygaard IE, Handa VL, Barnabei VM, Iglesia C. Effects of estrogen with and without progestin on urinary incontinence. JAMA. 2005;293:935-948.
22. Steinauer JE, Waetjen LE, Vittinghoff E, et al., for the Heart and Estrogen/Progestin Replacement Study Research Group. Postmenopausal Hormone Therapy Does It Cause Incontinence? Obstet Gynecol. 2005;106:940-945.
23. Waetjen LE, Dwyer PL. Estrogen therapy and urinary incontinence: what is the evidence and what do we tell our patients? Int Urogynecol J 2006; 17: 541-545.
24. Blakeman PJ, Hilton P, Bulmer JN. Oestrogen and progesterone receptor expression in the female lower urinary tract, with reference to oestrogen status. BJU Int. 2000;86:32-38.
25. Bernstein IT. The pelvic floor muscles: muscle thickness in healthy and urinary-incontinent women measured by perineal ultrasonography with reference to the effect of pelvic floor training. Estrogen receptor studies. Neurourol Urodyn. 1997;16:237-275.
26. Smith P, Heimer G, Norgren A, Ulmsten U. Localization of steroid hormone receptors in the pelvic muscles. Eur J Obstet Gynecol Reprod Biol. 1993;50:83-85.
27. Falconer C, Ekman-Ordeberg G, Blomgren B, et al. Paraurethral connective tissue in stress-incontinent women after menopause. Acta Obstet Gynecol Scand. 1998;77:95-100.
28. Jackson S, James M, Abrams P The effect of oestradiol on vaginal collagen metabolism in postmenopausal women with genuine stress incontinence. BJOG 2002;109:339-344.
29. Gebhardt J, Richard D, Barrett T. Expression of estrogen receptor isoforms alpha and beta messenger RNA in vaginal tissue of premenopausal and postmenopausal women. Am J Obstet Gynecol. 2001;185:1325-1330.
30. Fu X, Rezapour M, Wu X, Li L, Sjogren C, Ulmsten U. Expression of estrogen receptor-alpha and -beta in anterior vaginal walls of genuine stress incontinent women. Int Urogynecol J Pelvic Floor Dysfunct. 2003;14:276-281.
31. Sartori MG, Girǎo MJ, de Jesus Simoes M, Sartori JP, Baracat EC, Rodrigues de Lima G. Quantitative evaluation of collagen and muscle fibers in the lower urinary tract of castrated and under-hormone replacement female rats. Clin Exp Obstet Gynecol. 2001;28:92-96.
32. Fleischmann N, Christ G, Sclafani T, Melman A. The effect of ovariectomy and long-term estrogen replacement on bladder structure and function in the rat. J Urol. 2002;168:1265-1268.
33. Robinson D, Rainer RO, Washburn SA, Clarkson TB. Effects of estrogen and progestin replacement on the urogenital tract of the ovariectomized cynomolgus monkey. Neurourol Urodyn. 1996;15:215-221.
34. Endo RM, Girao MJ, Sartori MG, Simoes MJ, Baracat EC, Rodrigues de Lima G. Effect of estrogen-progestogen horonal replacement therapy on periurethral and bladder vessels. Int Urogynecol J Pelvic Floor Dysfunct. 2000;11:120-123.
35. Zoubina EV, Mize AL, Alper RH, Smith PG. Acute and chronic estrogen supplementation decreases uterine sympathetic innervation in ovariectomized adult virgin rats. Histol Histopathol. 2001;16:989-996.
36. Brown JS, Grady D, Ouslander JG, Herzog AR, Varner RE, Posner SF. Prevalence of urinary incontinence and associated risk factors in postmenopausal women. Heart and Estrogen/ProgestinReplacement Study (HERS) Research Group. Obstet Gynecol. 1999;94:66-70.
37. Lose G, Englev E. Oestradiol-releasing vaginal ring versus oestriol vaginal pessaries in the treatment of bothersome lower urinary tract symptoms. Br J Obstet Gynaecol. 2000;107:1029-1034.